共1页/4条首页上一页1下一页尾页
回复:4 阅读:4822
UPMC section of Lab Medicine-Division of Molecular Diagnostics

cqzhao 离线

帖子:5518
粉蓝豆:1071
经验:5755
注册时间:2008-09-29
加关注  |  发消息
楼主 发表于 2012-02-29 11:15|举报|关注(0)
浏览排序[ 顺序 逆序 楼主 支持 精彩 ]  快捷回复

 The division belongs to clinical pathology. MAP belongs to surgical pathology

标签:
0
添加参考诊断
×参考诊断
  

cqzhao 离线

帖子:5518
粉蓝豆:1071
经验:5755
注册时间:2008-09-29
加关注  |  发消息
1 楼    发表于2012-02-29 11:15:47举报|引用
返回顶部 | 快捷回复

 

Molecular Diagnostics

(Division of Molecular Diagnostics Web Site)

This Division integrates molecular biology into the practice of pathology, translating complex molecular biology techniques into simplified technical protocols suitable for use in the hospital diagnostic laboratory. Please visit our web site for further, in depth, information on services provided by the Molecular Diagnostics Laboratory.

HIGHLIGHTS
  • Diagnoses and classifies neoplastic diseases with new, molecular-based markers to give additional insight into both prognosis and therapeutic monitoring of cancer patients for residual disease

  • Aids in the diagnosis of acquired infectious diseases, with emphasis on DNA and RNA viruses associated with solid organ transplantation.

  • Offers to local and national clients comprehensive anlaysis encompassing a range of simple and complex inherited disorders to include pancreatic disease, hereditary paraganglioma / pheochromocytoma, and mitochondrial disorders.

  • Investigates the molecular basis of cell survival and programmed cell death and oxidative mechanisms of disease, viral latency, hereditary cancer and genetic disorders.

(Division of Molecular Diagnostics Web Site)
0
回复

cqzhao 离线

帖子:5518
粉蓝豆:1071
经验:5755
注册时间:2008-09-29
加关注  |  发消息
2 楼    发表于2012-02-29 11:16:46举报|引用
返回顶部 | 快捷回复

The Division of Molecular Diagnostics is part of the Department of Pathology at the University of Pittsburgh Medical Center (UPMC). The Division is located in the midst of a large hospital complex and performs testing on a variety of sample types over a wide range of diseases. The Division offers about 60 different tests and processes over 25,000 samples each year in Infectious Diseases, Genetics, and Cancer Diagnostics.

Fellowship training opportunities are available for physicians who have completed an accredited residency in Anatomic and/or Clinical Pathology or an accredited residency or fellowship in Medical Genetics.

0
回复

cqzhao 离线

帖子:5518
粉蓝豆:1071
经验:5755
注册时间:2008-09-29
加关注  |  发消息
3 楼    发表于2012-02-29 11:17:31举报|引用
返回顶部 | 快捷回复

 

Division Faculty

Jeffrey A. Kant, MD, PhD,   Division Director
Marie C. DeFrances, MD, PhD   Assistant Director
Zoltan Oltvai, MD
Tim D. Oury MD, PhD



0
回复

cqzhao 离线

帖子:5518
粉蓝豆:1071
经验:5755
注册时间:2008-09-29
加关注  |  发消息
4 楼    发表于2012-02-29 11:19:21举报|引用
返回顶部 | 快捷回复

Lists of the Tests performed in this division

A - B     (Back to top)

Adenovirus, qualitative realtime PCR

Bacterial strain identification (rRNA gene sequence analysis)

BCL2/Immunoglobulin heavy chain translocation, t(14;18) ?Major breakpoint cluster region (Mbr), PCR

BCL2/Immunoglobulin heavy chain translocation, t(14;18) ?Major breakpoint cluster region (Mbr), Southern blot

BCL2/Immunoglobulin heavy chain translocation, t(14;18) ?minor cluster region (mcr), PCR

BCL2/Immunoglobulin heavy chain translocation, t(14;18) ?minor cluster region (mcr), Southern blot

BCL6 translocation, t(3;others), Southern blot

BCR-ABL translocation (M-BCR: major breakpoint), t(9;22) (CML, some cases of ALL), quantitative real-time RT-PCR

BCR-ABL translocation (m-BCR: minor breakpoint), t(9;22) (some cases of ALL), quantitative real-time RT-PCR

BK (Polyoma) virus, Quantitative PCR

BRCA 1 and 2 (Ashkenazi Jewish Screening Panel) for hereditary breast cancer

Breast Cancer, hereditary (BRCA1/2 Ashkenazi Jewish Screening Panel)

C - D     (Back to top)

CLL sequencing analysis for mutated/non-mutated status of immunoglobulin heavy chain gene variable regions

CMV (Cytomegalovirus), PCR

c-MYC translocations, t(8;14) and t(8;22) and t(2;8), Southern blot

Consultation

Cystic Fibrosis (ACMG 23 mutation panel) with polyT analysis

Cytomegalovirus (CMV), qualitative realtime PCR

DNA Isolation and Storage

E - F     (Back to top)

EBV (Epstein-Barr Virus) Clonality Studies, Southern blot

EBV (Epstein-Barr Virus), qualitative realtime PCR

 

Epstein-Barr Virus (EBV) Clonality Studies, Southern blot

Epstein-Barr Virus (EBV), qualitative realtime PCR

 

Factor II (Prothrombin 20210G>A) (Invader)

Factor V Leiden (Invader)

Fragile X Syndrome

G - H     (Back to top)

HBV (Hepatitis B Virus), PCR , quantitative in plasma, qualitative for liver

HCV (Hepatitis C Virus), genotype (DNA sequence analysis)

HCV (Hepatitis C Virus), genotype (Invader)

HCV (Hepatitis C Virus), RT-PCR, quantitative in plasma, qualitative for liver

Hemochromatosis

Hepatitis B (HBV), PCR , quantitative in plasma, qualitative for liver

Hepatitis C virus (HCV) genotype, DNA sequence analysis

Hepatitis C virus (HCV), genotype (Invader)

Hepatitis C Virus (HCV), RT-PCR, Quantitative

Hereditary Pancreatic carcinoma (PALLD gene sequencing)

Hereditary Pancreatitis (R122H, N29I, A16V)

Hereditary Paraganglioma/pheochromocytoma (SDHD / SDHB / SDHC), full gene sequence analysis

Herpes Simplex Virus (Types 1,2), qualitative realtime PCR

HIV-1 (Human Immunodeficiency Virus, Type 1), Quantitative RT-PCR (Viral Load) , ultrasensitive

HSV-1 (Herpes Simplex Virus, Type 1), qualitative realtime PCR

HSV-2 (Herpes Simplex Virus, Type 2), qualitative realtime PCR

HTLV-I (Human T-cell Leukemia Virus, Type I), qualitative realtime PCR

HTLV-II (Human T-cell Leukemia Virus, Type II), qualitative realtime PCR

Human Immunodeficiency Virus, Type 1 (HIV-1), Quantitative RT-PCR (Viral Load), ultrasensitive

Human T-cell Leukemia Virus, Type 1 (HTLV-1), qualitative realtime PCR

Human T-cell Leukemia Virus, Type II (HTLV-II), qualitative realtime PCR

Huntington Disease
·  Specific Test Information

·  Symptomatic Testing Information for Patients

·  Presymptomatic Testing Information for Patients

I - L     (Back to top)

Immunoglobulin heavy chain gene rearrangement, PCR

Immunoglobulin heavy chain gene rearrangement, Southern Blot

Isovaleric Acidemia (Isovaleryl-CoA-Dehydrogenase gene sequencing)

JAK2 V617F mutation testing (PCR), myeloproliferative disorders

JC (Polyoma) virus, qualitative real-time PCR

Kennedy Disease (Spinal & Bulbar Muscular Atrophy), X-linked

Lymphedema distichiasis syndrome (FOXC2 gene sequencing)

M - O     (Back to top)

Malignant hyperthermia (RYR1 gene sequenced analysis, partial)

MCAD deficiency (medium chain Acyl-CoA-Dehydrogenase), exon 11 (>90% mutations)

MELAS (Mitochondrial Encephalopathy, Lactic Acidosis and Stroke Syndrome)

MEN2A/B (c-RET oncogene) for Multiple Endocrine Neoplasia, Type 2, exons 10,11,13,14,15,16)

MERRF (Myoclonic Epilepsy with Ragged Red Fibers)

Methylenetetrahydrofolate reductase (MTHFR), 677C>T Thermolabile polymorphism (Invader)

Mitochondrial Mutation Panel (MELAS, MERRF, NARP)

 

Molecular Diagnostics consultation

MTHFR, 677C>T Thermolabile Polymorphism (Invader)

Multiple Endocrine Neoplasia, Type 2 (MEN 2A/2B, c-RET oncogene) (exons 10,11,13,14,15,16)

NARP (Neuropathy, Ataxia, and Retinitis Pigmentosa)

P - R     (Back to top)

Pancreatic secretory trypsin inhibitor (SPINK1, a.k.a. Serine protease inhibitor, kazal type 1) , PCR

PML;RAR-alpha translocation, t(15;17), RT-PCR, qualitative, nested

PML;RAR-alpha translocation, t(15;17), RT-PCR, quantitative

Polyoma (BK or JC) Virus, auantitative or qualitative real-time PCR

Prothrombin 20210G>A (Factor II)

RNA Isolation and Storage

RYR1 gene sequence analysis, partial (Malignant hyperthermia)

S     (Back to top)

SDHB (Hereditary Paraganglioma/pheochromocytoma), full gene sequencing

SDHC  (Hereditary Paraganglioma/pheochromocytoma), full gene sequencing

SDHD  (Hereditary Paraganglioma/pheochromocytoma), full gene sequencing

Serine protease inhibitor, kazal type 1 (SPINK1), PCR

SMA (Spinal Muscular Atrophy), autosomal recessive (types I, II, and III) , PCR (diagnostic, not carrier)

Spinal & Bulbar Muscular Atrophy, X-linked (Kennedy Disease)

Spinal Muscular Atrophy, autosomal recessive (types I, II, and III), PCR (diagnostic, not carrier)

SPINK1 (Serine protease inhibitor, kazal type 1), PCR

Storage, DNA and/or RNA

T     (Back to top)

t(11q23;others), MLL translocation, Southern blot

t(14;18) (BCL2;IGH) ?Major breakpoint cluster region (Mbr), PCR

t(14;18) (BCL2;IGH) ?Major breakpoint cluster region (Mbr), Southern blot

t(14;18) (BCL2;IGH) ?minor cluster region (mcr), PCR

t(14;18) (BCL2;IGH) ?minor cluster region (mcr), Southern blot

t(15;17), PML;RAR-alpha, RT-PCR, qualitative, nested

t(15;17), PML;RAR-alpha, RT-PCR, quantitative

t(3;others), BCL6;others, Southern blot

t(8;others), c-MYC;Ig, Southern blot

 

t(9;22), BCR-ABL translocation (M-BCR: Major breakpoint)(CML, some cases of ALL), quantitative real-time RT-PCR

t(9;22), BCR-ABL translocation (m-BCR: minor breakpoint) (some cases of ALL), quantitative real-time RT-PCR

T-cell receptor beta chain gene rearrangement, Southern Blot

T-cell receptor gamma chain gene rearrangement, PCR

U - Z     (Back to top)

Varicella Zoster Virus (VZV), qualitative realtime PCR

VZV (Varicella Zoster Virus), qualitative realtime PCR

0
回复
回复:4 阅读:4822
共1页/4条首页上一页1下一页尾页
【免责声明】讨论内容仅作学术交流之用,不作为诊疗依据,由此而引起的法律问题作者及本站不承担任何责任。
快速回复
进入高级回复
您最多可输入10000个汉字,按 "Ctrl" + "Enter" 直接发送
搜索回复/乘电梯 ×
按内容
按会员
乘电梯
合作伙伴
友情链接